When professional sports organizations need to investigate positive athlete tests and analyze implicated supplements, they send samples to SMRTL's laboratory
Although the benefits are clear, what remains uncertain is whether all of these benefits was down to the weight alone
Do not use if cloudy or contains particles
Food and Drug Administration (FDA) to treat obesity, expanding their use beyond the original purpose of diabetes management, demand for these drugs is skyrocketing and employers are struggling to weigh the high costs of coverage
Mitochondrial dysfunction and chronic inflammation in polycystic ovary syndrome
GLP-1 agonists were originally approved to treat Type 2 Diabetes (T2D) but their most recent incarnations, which consist of both next generation GLP-1s and combinations (Ozempic, Mounjaro, Wegovy, Zepbound), have moved beyond the realm of T2D into the treatment of obesity